Sunday, February 21, 2021

Israeli study shows Pfizer vaccine 94% effective

Researchers tested 600,000 subjects who had received the recommended two doses of the US-German Pfizer/BioNTech vaccine and the same number of people who had not been inoculated.

Other News

571,802 anggota barisan hadapan daftar untuk imunisasi Covid-19, kata Khairy

Malaysia mencatatkan sejarah apabila kumpulan pertama vaksin Covid-19 Pfizer-BioNTech tiba di KLIA pada jam 10.07 pagi tadi.

Muhyiddin ucap selamat maju jaya kepada calon SPM

Seramai 401,105 pelajar seluruh negara akan menduduki SPM 2020 dalam suasana pembudayaan norma baru.

Kes baru Covid-19 kembali melebihi 3,000

4,456 dilaporkan pulih, 5 lagi kematian.

New cases top 3,000 again

3,297 new cases, 4,456 recoveries.

Sumbangan ayam daripada Anwar timbulkan rasa tak puas hati penyandang kerusi PKR?

Sumbangan ayam daripada Anwar itu turut menerima kritikan termasuk cakap-cakap Afdlin Shauki sebagai calon Wangsa Maju.

Israel’s largest healthcare provider said Sunday a study of more than half a million fully vaccinated Israelis indicated the Pfizer/BioNTech jab gave 94% protection against Covid-19.

Clalit Health Services said that in a groundbreaking project its researchers tested 600,000 subjects who had received the recommended two doses of the US-German Pfizer/BioNTech vaccine and the same number of people who had not been inoculated.

“There was a 94% reduction in the rate of symptomatic infection and a 92% decrease in the rate of serious illness compared to 600,000 similar (subjects) who were not vaccinated,” Clalit said in a Hebrew-language statement.

“Vaccine efficacy is maintained in all age groups, including those aged 70+,” it added.

Israel’s mass vaccination campaign has seen 3.8 million people receive a first dose, while 2.4 million have also received a second shot.

The country of nine million people, which is currently easing restrictions imposed during its third nationwide lockdown, is aiming to vaccinate everyone over the age of 16 by the end of March.

“The publication of preliminary results at this stage is intended to emphasise to the unvaccinated population that the vaccine is highly effective and prevents serious morbidity,” Clalit said Sunday.

It added that the study covered people who had received the second shot at least seven days before being tested, and would be expanded in future.

“With each additional week that passes, we will be able to make the assessment more accurate.”

Accuracy would improve as subjects are tested after 14 days or more from the second dose, it said.

Israel has so far relied on only the Pfizer/BioNTech vaccine, although it holds a small stock of the vaccine developed by US biotech firm Moderna.

Israel secured plentiful supplies of vaccine from Pfizer after striking a data-sharing deal with the US manufacturer.

The agreement stipulates that the Jewish state, which has one of the world’s most sophisticated medical data systems, will share real-time information with Pfizer on the vaccine’s impact, including on progress towards herd immunity.

Clalit is the biggest of Israel’s four health service providers, which collectively provide healthcare to the entire population.

They are directly responsible for vaccinations and collecting data on their impact.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

New cases top 3,000 again

3,297 new cases, 4,456 recoveries.

Vaccination will begin earlier, PM and health DG to get first jabs

More than 300,000 doses of the Pfizer vaccine arrived today.

Pemberian vaksin Covid-19 diawalkan, PM, KP Kesihatan penerima pertama

Perdana Menteri Muhyiddin Yassin dan Ketua Pengarah Kesihatan Dr Noor Hisham Abdullah antara penerima awal vaksin pada Rabu ini.

Vaksin Covid-19 pertama untuk Malaysia tiba pagi ini

Malaysia akan dapat memulakan Program Imunisasi Covid-19 Kebangsaan lima hari lagi.

Covid-19 looms large over Sarawak river town

Townsfolk worry that what promised to be a boom could turn into a bust thanks to the effects of the pandemic.